NHS Endurance Edge
Proprietary Blend (we offer both liquid and capsule
forms):
Glucuronolactone
Malic Acid
Magnesium malate
Vitamin C
Citric acid
L-Arginine
L-Citrulline
L-Taurine
NHS ENDURANCE EDGE
The endurance athlete pre-workout formula may provide a source
of ATP - fuel the body may need as a fuel source.
Arginine once again acts to increase blood flow to the body
by relaxing the endothelial cells of the circulatory system
which provides a lower blood pressure with increased blood
flow that moves energy in and waste products out more efficiently.
The remaining materials in the enduro formula provides for
the conversion of waste products generated by the athletic activity
to a form that is removable by the body.
This becomes very important as fatigue arises from the waste
by-products associated with energy production and consumption.
Explanation of Key Ingredients:
Citrulline is an amino acid that supports the body in optimizing
blood flow through its conversion to L-arginine and then nitric
oxide. Nitric oxide is involved in vasodilatation, and low levels
are associated with mental and physical fatigue and sexual dysfunction.
Citrulline, which is considered a non-essential amino acid
synthesized in the intestinal tract from Glutamine, converts
to Arginine in the endothelial cells. This biochemical process
involves L-Aspartate and the enzymes Argininosuccinate Synthetase
and Argininosuccinate Lyase, in the presence of ATP. Arginine
is important for Nitric Oxide production for cardiovascular health;
however, most Arginine is utilized in the liver and kidneys,
and only a fraction is available for this purpose. Since Citrulline
is a precursor to Arginine, it allows for increased and sustained
Nitric Oxide production in the endothelium for support of circulatory
function.
Oral Citrulline supplementation provides a readily available
source of Citrulline for this purpose, and some recent research
further indicates that Citrulline may be the preferred source
of cellular Arginine. In addition Citrulline also increases energy,
stimulates the immune system, and is essential for Urea Cycle
function as well.
Glucuronolactone -is a fascinating compound and appears not
only to be safe, but hepatoprotective. A pathway of interest
is the clearance of toxic metabolites and liberation of lipophillic
steroids. DGL may increase the bioavailability of an exogenous
hormone being administered, thereby increasing the direct effect
elicited.
Moreover, the compound could remove metabolites that could potentially
be hepatotoxic and may reverse prior liver damage. DGL may also
be an ergogenic aid by protecting glycogen stores and their synthesis.
Lastly, it may be joint and tendon protective benefiting the
athlete by potentially reducing risk of injury and associated
pain.
This fully referenced article should serve as an exhaustive
resource for the athlete, through scientifically-based research
and theory. I would appreciate feedback from readers that have
supplemented with the compound (especially in its pure form)
on its performance, liver, and joint benefits
Malic acid -is both derived from food sources and synthesized
in the body through the citric acid (Krebs) cycle. Its importance
to the production of energy in the body during both aerobic and
anaerobic conditions is well established. Under aerobic conditions,
the oxidation of malate to oxaloacetate provides reducing equivalents
to the mitochondria through the malate-aspartate redox shuttle.
During anaerobic conditions, where a buildup of excess of reducing
equivalents inhibits glycolysis, malic acids simultaneous reduction
to succinate and oxidation to oxaloacetate is capable of removing
the accumulating reducing equivalents. This allows malic acid
to reverse hypoxias inhibition of glycolysis and energy production.
This may allow malic acid to improve energy production in FM,
reversing the negative effect of the relative hypoxia (a shortage
of oxygen in the body).
*References:
Dunne L, Worley S, Macknin M. Ribose versus dextrose supplementation,
association with rowing performance: a double-blind study.
Clin J Sport Med 2006;16:68-71.
Falk DJ, Heelan KA, Thyfault JP, Koch AJ. Effects of effervescent
creatine, ribose, and glutamine supplementation on muscular
strength, muscular endurance, and body composition. Strength
Cond Res 2003;17:810-6.
Foker JE, Einzig S, Wang T. Adenosine metabolism and myocardial
preservation. Consequences of adenosine catabolism on myocardial
high-energy compounds and tissue blood flow. J Thorac Cardiovasc
Surg 1980;80:506-16.
Fox IH, Kelley WN. Phosphoribosylpyrophosphate in man: biochemical
and clinical significance. Ann Intern Med 1971;74:424-33.
Gross M, Reiter S, Zollner N. Metabolism of D-ribose administered
continuously to healthy persons and to patients with myoadenylate
deaminase deficiency. Klin Wochenschr 1989;67:1205-13.
Hegewald MG, Palac RT, Angello DA, et al. Ribose infusion accelerates
thallium redistribution with early imaging compared with late
24-hour imaging without ribose. J Am Coll Cardiol 1991;18:1671-81.
Hellsten-Westing Y, Norman B, Balsom PD, et al. Decreased resting
levels of adenine nucleotides in human skeletal muscle after
high-intensity training. J Appl Physiol 1993;74:2523-8.
Kerksick C, Rasmussen C, Bowden R, et al. Effects of ribose
supplementation prior to and during intense exercise on anaerobic
capacity and metabolic markers. Int J Sport Nutr Exerc Metab
2005;15:653-64.
Muller C, Zimmer HG, Gross M, et al. Effect of ribose on cardiac
adenine nucleotides in a donor model for heart transplantation.
Eur J Med Res 1998;3:554-8.
Omran H, Illien S, MacCarter D, St Cyr J, Luderitz B. D-Ribose
improves diastolic function and quality of life in congestive
heart failure patients: a prospective feasibility study. Eur
J Heart Fail 2003;5:615-9.
Op 't Eijnde B, Van Leemputte M, Brouns F, et al. No effects
of oral ribose supplementation on repeated maximal exercise
and de novo ATP resynthesis. J Appl Physiol 2001;91:2275-81.
Pasque MK, Wechsler AS. Metabolic intervention to affect myocardial
recovery following ischemia. Ann Surg 1984;200:1-12.
Perkowski D, Wagner S, Marcus A, St. Cyr J. Ribose enhances
ventricular function following off pump coronary artery bypass
surgery. J Altern Complement Med 2005;11:745.
Perlmutter NS, Wilson RA, Angello DA, et al. Ribose facilitates
thallium-201 redistribution in patients with coronary artery
disease. J Nucl Med 1991;32:193-200.
Peveler WW, Bishop PA, Whitehorn EJ. Effects of ribose as an
ergogenic aid. J Strength Cond Res 2006;20:519-22.
Pliml W, von Arnim T, Stalein A, et al. Effects of ribose on
excercise-induced ischaemia in stable coronary artery disease.
Lancet 1992;340:507-10.
St Cyr JA, Bianco RW, Schneider JR, et al. Enhanced high energy
phosphate recovery with ribose infusion after global myocardial
ischemia in a canine model. J Surg Res 1989;46:157-62.
Stathis CG, Febbraio MA, Carey MF, et al. Influence of sprint
training on human skeletal muscle purine nucleotide metabolism.
J Appl Physiol 1994;76:1802-9.
|